Terms: = Leukemia AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG AND Treatment
33 results:
1. Identification of cells of leukemic stem cell origin with non-canonical regenerative properties.
Hollands CG; Boyd AL; Zhao X; Reid JC; Henly C; ElRafie A; Boylan D; Broder E; Kalau O; Johnson P; Mark A; McNicol J; Xenocostas A; Berg T; Foley R; Trus M; Leber B; Garcia-Horton A; Campbell C; Bhatia M
Cell Rep Med; 2024 Apr; 5(4):101485. PubMed ID: 38582086
[TBL] [Abstract] [Full Text] [Related]
2. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
[TBL] [Abstract] [Full Text] [Related]
3. The impact of cytogenetic risk on the outcomes of allogeneic hematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukemia: On behalf of the acute leukemia working party (ALWP) of the European group for blood and marrow transplantation (EBMT).
Poiani M; Labopin M; Battipaglia G; Beelen DW; Tischer J; Finke J; Brecht A; Forcade E; Ganser A; Passweg JR; Labussiere-Wallet H; Yakoub-Agha I; Schäfer-Eckart K; Kroeger N; Guffroy B; Ruggeri A; Esteve J; Nagler A; Mohty M
Am J Hematol; 2021 Jan; 96(1):40-50. PubMed ID: 32944990
[TBL] [Abstract] [Full Text] [Related]
4. [Optimization of ATG dose in haploid hematopoietic stem cell transplantation for hematologic malignancies].
Zhou X; Lu X; Tang L; Yan H; Chen WL; Shi W; Zhong ZD; You Y; Xia LH; Hu Y; Wang HF
Zhonghua Xue Ye Xue Za Zhi; 2020 Jul; 41(7):557-563. PubMed ID: 32810962
[No Abstract] [Full Text] [Related]
5. Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
Bararia D; Hildebrand JA; Stolz S; Haebe S; Alig S; Trevisani CP; Osorio-Barrios F; Bartoschek MD; Mentz M; Pastore A; Gaitzsch E; Heide M; Jurinovic V; Rautter K; Gunawardana J; Sabdia MB; Szczepanowski M; Richter J; Klapper W; Louissaint A; Ludwig C; Bultmann S; Leonhardt H; Eustermann S; Hopfner KP; Hiddemann W; von Bergwelt-Baildon M; Steidl C; Kridel R; Tobin JWD; Gandhi MK; Weinstock DM; Schmidt-Supprian M; Sárosi MB; Rudelius M; Passerini V; Mautner J; Weigert O
Cell Rep; 2020 May; 31(5):107522. PubMed ID: 32330423
[TBL] [Abstract] [Full Text] [Related]
6. Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center study.
Leeksma AC; Baliakas P; Moysiadis T; Puiggros A; Plevova K; Van der Kevie-Kersemaekers AM; Posthuma H; Rodriguez-Vicente AE; Tran AN; Barbany G; Mansouri L; Gunnarsson R; Parker H; Van den Berg E; Bellido M; Davis Z; Wall M; Scarpelli I; Österborg A; Hansson L; Jarosova M; Ghia P; Poddighe P; Espinet B; Pospisilova S; Tam C; Ysebaert L; Nguyen-Khac F; Oscier D; Haferlach C; Schoumans J; Stevens-Kroef M; Eldering E; Stamatopoulos K; Rosenquist R; Strefford JC; Mellink C; Kater AP
Haematologica; 2021 Jan; 106(1):87-97. PubMed ID: 31974198
[TBL] [Abstract] [Full Text] [Related]
7. [Clinical analysis of a modified LMB89 Group C regimen in the treatment of pediatric high-risk Burkitt lymphoma].
Zhang M; Jin L; Yang J; Duan YL; Huang S; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2019 Aug; 40(8):633-638. PubMed ID: 31495128
[No Abstract] [Full Text] [Related]
8. Targeting PRMT1-mediated FLT3 methylation disrupts maintenance of MLL-rearranged acute lymphoblastic leukemia.
Zhu Y; He X; Lin YC; Dong H; Zhang L; Chen X; Wang Z; Shen Y; Li M; Wang H; Sun J; Nguyen LX; Zhang H; Jiang W; Yang Y; Chen J; Müschen M; Chen CW; Konopleva MY; Sun W; Jin J; Carlesso N; Marcucci G; Luo Y; Li L
Blood; 2019 Oct; 134(15):1257-1268. PubMed ID: 31395602
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of Residual Disease and TKI Duration Are Critical Predictive Factors for Molecular Recurrence after Stopping Imatinib First-line in Chronic Phase CML Patients.
Nicolini FE; Dulucq S; Boureau L; Cony-Makhoul P; Charbonnier A; Escoffre-Barbe M; Rigal-Huguet F; Coiteux V; Varet B; Dubruille V; Lenain P; Rousselot P; Rea D; Guerci-Bresler A; Legros L; Liu J; Gardembas M; Ianotto JC; Turlure P; Johnson-Ansah H; Martiniuc J; Jardel H; Joly B; Zunic P; Henni T; Villemagne B; Berger MG; Cayssials E; Guilhot F; Larosa F; Guilhot J; Etienne G; Mahon FX
Clin Cancer Res; 2019 Nov; 25(22):6606-6613. PubMed ID: 31292142
[TBL] [Abstract] [Full Text] [Related]
10. PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD
He X; Zhu Y; Lin YC; Li M; Du J; Dong H; Sun J; Zhu L; Wang H; Ding Z; Zhang L; Zhang L; Zhao D; Wang Z; Wu H; Zhang H; Jiang W; Xu Y; Jin J; Shen Y; Perry J; Zhao X; Zhang B; Liu S; Xue SL; Shen B; Chen CW; Chen J; Khaled S; Kuo YH; Marcucci G; Luo Y; Li L
Blood; 2019 Aug; 134(6):548-560. PubMed ID: 31217189
[TBL] [Abstract] [Full Text] [Related]
11. Incidence of infections after therapy completion in children with acute lymphoblastic leukemia or acute myeloid leukemia: a systematic review of the literature.
Pelland-Marcotte MC; Hwee J; Pole JD; Nathan PC; Sung L
Leuk Lymphoma; 2019 Sep; 60(9):2104-2114. PubMed ID: 30774019
[TBL] [Abstract] [Full Text] [Related]
12. Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
Mo X; Zhang X; Xu L; Wang Y; Yan C; Chen H; Chen Y; Han W; Wang F; Wang J; Liu K; Huang X
Front Med; 2019 Jun; 13(3):354-364. PubMed ID: 30680605
[TBL] [Abstract] [Full Text] [Related]
13. Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study.
Leblond V; Aktan M; Ferra Coll CM; Dartigeas C; Kisro J; Montillo M; Raposo J; Merot JL; Robson S; Gresko E; Bosch F; Stilgenbauer S; Foà R
Haematologica; 2018 Nov; 103(11):1889-1898. PubMed ID: 29976743
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract] [Full Text] [Related]
15. [Anti-leukemia Effect and Mechanism of Oridonin on Imatinib-Sensitive and Imatinib-Resistant K562 Cells].
Shan QQ; Guo Y; Gong YP; Lin J; Wang YS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1378-1383. PubMed ID: 29070111
[TBL] [Abstract] [Full Text] [Related]
16. Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy.
Hiller JK; Schmoor C; Gaidzik VI; Schmidt-Salzmann C; Yalcin A; Abdelkarim M; Blagitko-Dorfs N; Döhner K; Bullinger L; Duyster J; Lübbert M; Hackanson B
Ann Hematol; 2017 Apr; 96(4):559-565. PubMed ID: 28058491
[TBL] [Abstract] [Full Text] [Related]
17. [Influence of Leukodeplated Blood Transfusion on Cellular Immunity of Acute leukemia Patients].
Lu YL; Zhang X; Wang YF; Ke SD; Ke JY; Liu GF; Chen SM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1221-5. PubMed ID: 27531804
[TBL] [Abstract] [Full Text] [Related]
18. Triggering the TCR Developmental Checkpoint Activates a Therapeutically Targetable Tumor Suppressive Pathway in T-cell leukemia.
Trinquand A; Dos Santos NR; Tran Quang C; Rocchetti F; Zaniboni B; Belhocine M; Da Costa de Jesus C; Lhermitte L; Tesio M; Dussiot M; Cosset FL; Verhoeyen E; Pflumio F; Ifrah N; Dombret H; Spicuglia S; Chatenoud L; Gross DA; Hermine O; Macintyre E; Ghysdael J; Asnafi V
Cancer Discov; 2016 Sep; 6(9):972-85. PubMed ID: 27354269
[TBL] [Abstract] [Full Text] [Related]
19. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract] [Full Text] [Related]
20. Synthesis of ZnPc loaded poly(methyl methacrylate) nanoparticles via miniemulsion polymerization for photodynamic therapy in leukemic cells.
Feuser PE; Gaspar PC; Jacques AV; Tedesco AC; Santos Silva MCD; Ricci-Júnior E; Sayer C; de Araújo PHH
Mater Sci Eng C Mater Biol Appl; 2016 Mar; 60():458-466. PubMed ID: 26706552
[TBL] [Abstract] [Full Text] [Related]
[Next]
